Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

Menafn | 21-03-2026 12:13pm |

(MENAFN - Investor Brand Network) Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs. The UK Medicines and Healthcare Products ...

Stay Updated with the Latest News!

Don't miss out on breaking stories and in-depth articles.